F. Christopher Bi - Concepedia

Concepedia

Author

F. Christopher Bi

Stanford University

Also Known As

Bi, F.C., F. Christopher Bi, Fanglong Bi

20

Publications

2.3K

Citations

10

H-Index

24

Concepts

All Affiliations

Stanford University Pfizer (United States)

FC

About

F. Christopher Bi is an author at Stanford University specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	243
2	Natural Sciences	3	3	334
3	Biochemistry	3	3	334
4	Engineering	2	2	144
5	Biomolecular Engineering	1	1	15

F. Christopher Bi

×

10

Publications

2.3K

Citations

10

H-Index

	Year	Citations
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists Beili Wu, Ellen Y. T. Chien, Clifford D. Mol, Science	2010	1.7K
The Practical Synthesis of a Novel and Highly Potent Analogue of Bryostatin Paul A. Wender, Jeremy L. Baryza, Chad Bennett, Journal of the American Chemical Society Macrocycle 1Pharmaceutical ChemistryMedicinal ChemistryPractical SynthesisAnti-cancer Agent	2002	154
Toward the ideal synthesis. New transition metal-catalyzed reactions inspired by novel medicinal leads Paul A. Wender, F. Christopher Bi, Gabriel G. Gamber, Pure and Applied Chemistry Medicinal ChemistryChemical EngineeringEngineeringAlkene MetathesisBiochemistry	2002	129
Asymmetric Synthesis of the Tricyclic Core of NGF-Inducing Cyathane Diterpenes via a Transition-Metal-Catalyzed [5 + 2] Cycloaddition Paul A. Wender, F. Christopher Bi, Michael A. Brodney, Organic Letters	2001	93
Studies on Oxidopyrylium [5 + 2] Cycloadditions: Toward a General Synthetic Route to the C12-Hydroxy Daphnetoxins Paul A. Wender, F. Christopher Bi, Nicole Buschmann, Organic Letters	2006	59
Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): Structure–activity relationships and strategies for the elimination of reactive metabolite formation Daniel P. Walker, F. Christopher Bi, Amit S. Kalgutkar, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural Sciences	2008	51
Catalytic, Asymmetric Synthesis of the C<sub>1</sub><sub>‘</sub>−C<sub>10</sub><sub>‘</sub> Segment of Pamamycin 621A Michael A. Calter, F. Christopher Bi Organic Letters	2000	40
Short-acting 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as orally-active calcium-sensing receptor antagonists Mary T. Didiuk, David A. Griffith, John W. Benbow, Bioorganic & Medicinal Chemistry Letters MedicinePharmacological AgentPharmacotherapyNon-peptide LigandPharmacology	2009	25
Novel syntheses of 3-anilino-pyrazin-2(1H)-ones and 3-anilino-quinoxalin-2-(1H)-ones via microwave-mediated Smiles rearrangement F. Christopher Bi, Gary E. Aspnes, Angel Guzmán-Pérez, Tetrahedron Letters Microwave-mediated Smiles RearrangementEngineeringOrganic ChemistryChemistrySynthetic Chemistry	2008	15
Astaxanthin protects oocyte maturation against cypermethrin-induced defects in pigs Jianqiang Sun, Jian Li, Yaodi Wang, Theriogenology InflammationAnimal PhysiologyOocyteMedicineVeterinary Science	2023	13

Page 1